Children's Hospital Colorado
Jean Mulcahy Levy, MD
Cancer and Blood Disorders

Jean Mulcahy Levy, MD

Assistant Professor

Hematology/Oncology - Pediatric , Pediatrics
Pediatric Cancer, Leukemia (Childhood), Brain Cancer

Hematology/Oncology - Pediatric , Pediatrics


Pediatric Cancer, Leukemia (Childhood), Brain Cancer

Meet Jean Mulcahy Levy, MD

I strive to provide the best care for my patients. I believe in treating the patient and family as a whole.

"What we're going to do is work together, and we're going to find the best treatment based on the unique situation of your child."

- Dr. Jean Mulcahy Levy

Get to know her background

My clinical interests focus on the care of children with tumors involving the brain and spinal cord, using a combination of therapies and coordinating services including surgery, radiation, and chemotherapy to improve outcomes for these patients.

Medical Education 2003

Oregon Health and Science University

Residency 2006

University of Arizona College of Medicine

Fellowship 2012

University of Colorado School of Medicine

Outstanding Abstract Award 2012

International Symposium on Pediatric Neuro-Oncology

For Patients:
My research interests focus on autophagy, a multi-step process that cancer can use to survive. It is possible to block this survival mechanism and hopefully make cancer easier to kill with other treatments like radiation and chemotherapy. My research has three goals to improve survival of kids with brain tumors. First, find which step of the process should be blocked to kill the most tumor cells. Second, to find which brain tumors depend most on autophagy to survive. And finally, to determine if a specific genetic mutation found in some pediatric brain tumors can identify patients who will most benefit from autophagy directed treatments.
For Referring Providers:
My laboratory research focus is the study of autophagy, a multi-step cellular catabolic process that turns over long-lived proteins and organelles and contributes to cell and organism survival during nutrient deprivation and other stresses. Autophagy has been shown to be important in the development of cancer and is a promising target for manipulation to improve cancer treatment and survival. My goal is to determine how to utilize autophagy to improve therapy for patients with malignant central nervous system (CNS) tumors. I also have a translational research interest in using the power of laboratory findings to identify patients at higher risk of adverse neurocognitive outcomes due to the negative effects of radiation and chemotherapy.

Assistant Professor